Rare congenital coronary anomaly - unroofed coronary sinus
1Children Clinic, University Hospital Clinical Centre, Banja Luka, Bosnia and Herzegovina
2University Children Hospital, Belgrade, Serbia
DOI: 10.22514/SV101.062015.16 Vol.10,Issue S1,June 2015 pp.58-60
Published: 22 June 2015
*Corresponding Author(s): DARIO ĐUKIĆ E-mail: firstname.lastname@example.org
In this paper we describe a case of an eight-month-old male infant who was diagnosed with an unroofed coronary sinus (UCS) that unusually presented with desaturation and cyanosis after surgical ventricular sep-tal defect (VSD) closure. The patient was initially diagnosed with congenital heart disease (CHD), perimembranous VSD as-sociated with mild stenosis of pulmonary arteries in early newborn period. Although the patient was regularly monitored by a paediatric cardiologist, and was even hos-pitalized twice due to deterioration of the initially diagnosed disease and the devel-opment of congestive heart failure (CHF) and arrhythmias, the UCS went unnoticed. The disease was unveiled completely after VSD was surgically closed and the patient’s condition deteriorated postoperatively with desaturation and cyanosis in the in-tensive care unit (ICU). On that same day the patient was reoperated on. UCS was closed with a pericardial patch, a persistent left superior vena cava ligated (PLSVC) and the patient successfully recovered. This case is an example that UCS is not only rare but is such an insidious congeni-tal heart disease, often masked with associ-ated heart defects. It should prompt every paediatric cardiologist to perform a careful examination of coronary sinus inflow tract or performance of contrast echocardiogra-phy in every suspicious case.
unroofed coronary sinus, coro-nary sinus septal defect, postoperative cya-nosis, echocardiography
DARIO ĐUKIĆ,STEVAN BAJIĆ,VOJISLAV PAREZANOVIĆ,STOJISLAV KONJEVIĆ,BARBARA STANIMIROVIĆ,VANJA BOBIĆ. Rare congenital coronary anomaly - unroofed coronary sinus. Signa Vitae. 2015. 10(S1);58-60.
1. Huang Xin-Sheng. Partially Unroofed Coronary Sinus. Circulation. October/2007;116(15):e373. [Medline].
2. Foster ED, Baeza OR, Farina MF, Shaher RM. Atrial septal defect associated with drainage of left superior vena cava to left atrium and absence of the coronary sinus. J Thorac Cardiovasc Surg. Nov 1978;76(5):718-20. [Medline].
3. Steele PM, Fuster V, Cohen M, et al. Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. Circulation. Nov 1987;76(5):1037-42. [Medline].
4. Attenhofer Jost CH, Connolly HM, Danielson GK, Dearani JA, Warnes CA, Jamil Tajik A. Clinical features and surgical outcome in 25 patients with fenestrations of the coronary sinus. Cardiol Young. Dec 2007;17(6):592-600. [Medline].
5. Xie MX, Yang YL, Cheng TO, Wang XF, Li K, Ren PP, Lü Q, Lin H, Li L. Coronary sinus septal defect (unroofed coronary sinus): echocardiographic diagnosis and surgical treatment. Int J Cardiol. 2013 Sep 30;168(2):1258-63.
6. Quaegebeur J, Kirklin JW, Pacifico AD, Bargeron LM Jr. Surgical experience with unroofed coronary sinus. Ann Thorac Surg. May 1979;27(5):418-25. [Medline].
7. Lee ME, Sade RM. Coronary sinus septal defect. Surgical considerations. J Thorac Cardiovasc Surg. Oct 1979;78(4):563-9. [Med-line].
8. Torres A, Gersony WM, Hellenbrand W. Closure of unroofed coronary sinus with a covered stent in a symptomatic infant. Catheter Cardiovasc Interv. 2007 Nov 1;70(5):745-8. PubMed PMID: 17563096.
9. Van Son JA, Black MD, Haas GS, Falk V, Hambsch J, Onnasch JF, Mohr FW. Extracardiac repair versus intracardiac baffle repair of complex unroofed coronary sinus. Thorac Cardiovasc Surg. 1998 Dec;46(6):371-4. PubMed PMID: 9928862.
Vol., Issue , Invalid dateTable of contents
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 0.5(2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.